Meet the leaders on stage June 10 at longevitydocs.™ Cannes Summit & Awards
In just a few weeks, the world's top physicians, researchers, and industry leaders come together at longevitydocs.™ Cannes to build the future of longevity medicine. Attend because you're building, scaling, leading.... and you need the people in this room. Explore the minds shaping longevity medicine on the stage with us June 10, 2026.
LD
longevitydocs™May 21, 2026 · 5 min read
In just a few weeks, 250+ physicians and 40+ speakers from 20+ countries come together to learn, build, and scale longevity medicine - and Cannes becomes the home of longevity medicine. This is where the frontier meets the clinic, research becomes practice, and you meet the people you'll build with for years to come.
Creating the experience in Cannes isn't about simply filling an agenda. Every person on this stage was curated because they are shaping the future of longevity medicine. Every moment is designed to mean something, one after the other. This is an intentional experience for physicians at every stage of the journey whether you are dreaming, building, or leading.
What's even more important to us is the voices on the stage that invite us in. The moments to connect with your peer community. Together we will advance the industry with evidence, ethics and equity... This is where longevity medicine becomes standard of care. Join us.
Longevity medicine is no longer a niche practice. It's becoming the default. The field is moving faster than consensus can form, and physicians are making critical decisions with incomplete information. The speakers on our stage aren't waiting for consensus, they're building it. They're the ones who prove what works, who scale what's evidence-based, who navigate the regulatory landscape, and who build practices that survive.
This is where you meet them. Where you understand not just what they know, but how they think. Where you see the patterns that connect senolytic science to peptide protocols, AI implementation to organizational strategy. From Mayo Clinic, Mount Sinai to L'Oréal, these are the physicians, scientists, investors, and innovators who aren't waiting for the future of longevity; they're building it. What you do with this knowledge is what defines the next decade of longevity medicine.
Community Comes First AT LONGEVITYDOCS
The most important moments at this summit don't happen on stage. They happen on the beach at lunch, in the run club rotation, in the garden during the reception. They happen when a physician from Singapore sits next to a founder from Boulder, when a health system CMO asks a clinical question that becomes the next day's conversation.
You're not here to sit and listen. You're here to build. With these people. Over these three days. This is where the longevity field actually moves forward—not in the keynotes, but in the relationships. In the advisory boards formed over dinner. In the referral networks that start with a conversation on the red carpet. In the clinical partnerships that reshape how medicine gets practiced.
Part I: Set The Standard – June 10 Agenda
LongevityDocs Run Club – La Croisette
The day starts the way longevity physicians should start every day: moving. We inaugurate the LongevityDocs Run Club with a 30-minute Zone 2 run along La Croisette. Every few minutes, you rotate conversation partners. By the time you reach the pier, you've already met your first circle. Led by Paul Alexandrov, MD, and Vikas Mehta, MD. Powered by Eli Health.
Terrasse French Breakfast – Vibrant Lounge
Croissant, coffee, and conversations after the run. The formal program hasn't started yet, but the community already has.
Welcome Back to Medicine
Thomas de Pariente, Deputy Mayor of Cannes, opens the summit and our founder, Dr. David Luu will kick us off with the question: how do we scale physician-led longevity care with evidence, ethics, and equity? This is why we're here.
longevitydocs Cannes June 10 Sessions at-a-Glance
TIME
SESSION
SPEAKER(S)
9:15
Targeting Aging: Science & Medicine
Nir Barzilai, MD
9:35
Session 2: loading soon...
10:30
The AI-Augmented Physician
Ami Bhatt, MD · Zahi Fayad, PhD
11:00
The GLP-1/Peptide Tsunami
Geoff Cook · Jeffrey Egler, MD
11:30
Chief Longevity Officer: A Role That's Barely a Title (Yet)
Three health system leaders
12:00
Leadership on the Beach — Networking Lunch
Mediterranean cuisine, Majestic Beach
2:00
From Lab to Shelf: Longevity at Global Scale
Vania Lacascade, PharmD
2:30
Longevity Founders Mode
Four practice founders
3:00
Confessions of a Longevity Doctor: After 20 Years, What Works
Elizabeth Yurth, MD · Cynthia Keller, MD
Targeting Aging – Nir Barzilai, MD
Where science is and where medicine should be. What's the state of longevity science in 2026, and where should medicine actually be? Barzilai has spent a career answering this question. The TAME trial exists because he proved something most physicians didn't believe: aging itself is treatable. Now the FDA agrees. On June 10, he opens the summit with the science that's changed everything—and what it means for how you practice right now.
What You'll Learn
The current state of senolytic science and aging biomarker research
What N-of-1 research means for truly personalized longevity interventions
How aging biomarkers are changing outcomes measurement and payer conversation
The AI-Augmented Physician – Ami Bhatt, MD & Zahi Fayad, PhD
AI is already changing how longevity physicians practice. Diagnostics are faster. Risk prediction is more accurate. Treatment can be personalized like never before. But how do you implement this safely? What does the regulatory landscape actually look like? And when AI makes a recommendation, who's responsible?
What You'll Learn
How AI is already changing diagnostics, risk prediction, and treatment planning in longevity programs
Regulatory evolution and what "safe implementation" looks like today
Data volume, liability, clinical responsibility, and how to scale responsibly
The GLP-1/Peptide Tsunami – Geoff Cook, Jeffrey Egler, MD & Steven Murphy, MD
Are all peptides created equal? Patients want GLP-1s. Your competitors are launching peptide programs. Regulations are shifting. How do you build a safe, evidence-based, profitable peptide strategy in 2026? Three leaders who've done this—from biotech to pharmacy to practice—unpack what actually works.
What You'll Learn
Latest research on GLP-1s and peptide-based longevity protocols
Why major platforms are acquiring 503A pharmacies and what it signals
FDA reclassification, compliance, and how to design an evidence-based peptide strategy
Chief Longevity Officer – Dawn Mussallem, DO, Jessica Shepherd, MD & Saad Alam
A role that's barely a title (yet). One that will be everywhere by 2027. Health systems are asking: Who owns our longevity strategy? Three leaders building this role from scratch map out what it actually looks like. A panel mapping out a role that barely exists, and is about to be everywhere.
What You'll Learn
What a Chief Longevity Officer actually owns—clinically and strategically
Org chart placement, funding mechanisms, and how impact is measured
How to position yourself or your physician leaders for these emerging roles
From Lab to Shelf – Vania Lacascade, PharmD
Inside Lancôme's journey from longevity science to global launch. What happens when a Fortune 500 beauty company decides longevity science is its future? How do you move from diagnostic insight to technology to product at global scale? Lacascade has done this. The insights she's learned are adaptable to your own practice, even if you're not building for billions.
What You'll Learn
Moving from diagnostic to technology to product at global scale
Building partnerships with tech, biotech, and research institutions
Running innovation in an organization with billions in resources
Behind the practice: the wins, the scars, the lessons. Four physicians building four different longevity models in different markets. They've made mistakes that cost time and money. They've been tempted to quit. But they've also learned what actually works. This is the session where they share it. Founders share their journeys building longevity practices: from solo to 65-person teams, from zero patients to six-month waitlists, from community-building to brick-and-mortar centers.
What You'll Learn
How to avoid classic year-one traps: hiring, market positioning, cash flow
Navigating institutional resistance and competitive markets
How to leverage community to speed up learning and de-risk big bets
Confessions of a Longevity Doctor – Elizabeth Yurth, MD & Cynthia Keller, MD
After 20 years: what works, what's missing. An honest conversation about two decades on the frontier of longevity medicine. Which therapies have stood the test of time? Which ones looked promising but didn't? And what are the unglamorous, consistent interventions that actually move the needle in real patients?
What You'll Learn
Which therapies—from supplements to stem cells to novel peptides—have stood the test of time
What remains unproven, oversold, or too new to confidently recommend
The foundations that consistently move the needle in real patients
Part II: Celebrating Excellence in Longevity Medicine
June 10 ends where every great gathering should: together. The black-tie gala at the iconic Carlton Hotel is the most exclusive night in longevity medicine: one red carpet, one room, one community.
Garden Reception – Carlton Hotel
In the tropical gardens, powered by Hims & Hers. First drinks, first photos, the first time the CLD cohort, Faculty, and Awardees are in the same space.
Certified Longevitydocs CLD Graduation – Class of 2026
We celebrate a cohort of physicians who completed 100 hours of evidence-based longevity medicine training and earn the CLD certification. This will become a credential the field will remember.
Longevitydocs Awards – Grand Salon
Five awards, one message: we recognize the people setting the standard.
Frequently Asked Questions About longevitydocs Cannes 2026
What is longevitydocs Cannes 2026?
longevitydocs Cannes 2026 is the world's premier gathering of physicians, researchers, and leaders in longevity medicine. Held at the Carlton Hotel in Cannes, France, it brings together 250+ physicians, 40+ speakers from 20+ countries to learn, build, and scale evidence-based longevity medicine.
Who are the speakers at longevitydocs Cannes 2026?
40+ speakers including Nir Barzilai, MD (Academy of Geroscience), Ami Bhatt, MD (American College of Cardiology), Zahi Fayad, PhD (Mount Sinai), and leaders from ARPA-H, Hims & Hers, Fountain Life, and more. See the full speaker list and session details.
Physicians building, scaling, or leading longevity medicine. Health system executives. Researchers in aging and healthspan. Entrepreneurs in longevity tech. Anyone advancing evidence-based longevity care and wanting to connect with the field's leading voices.
What is the longevitydocs Certified Longevity Doctor (CLD) credential?
The CLD is the first credentialing program in longevity medicine. 100 hours of evidence-based training covering aging biomarkers, clinical protocols, and practice implementation. Completion is celebrated at the June 10 gala in Cannes.
250+ Physicians. 40+ Leaders. One Day.Join Us in CannesThe conversations on June 10 will shape the next year of longevity medicine. Be in the room. Meet the people. Ask the hard questions. Find your community.
About Dr. David LuuDr. David Luu, MD, is the Founder of longevitydocs™. He is a trained pediatric cardiac surgeon, longevity tech entrepreneur, and philanthropist who helps physicians, organizations, and leaders build the global infrastructure of longevity medicine.About longevitydocs™longevitydocs™ is the world's leading longevity physician community. Over 1,000 physicians across 50+ countries united by one conviction: every doctor should be a longevity doctor. We build the infrastructure, education, and community physicians need to make longevity medicine their default practice.
Editorial Disclaimer
This article is published exclusively for licensed healthcare professionals. It is not intended for consumers or patients.
All content is for continuing medical education and professional information purposes. It reflects emerging research, science, and technology with implications for medical practice. It does not constitute medical advice, clinical recommendations, or treatment guidance for any individual patient.
By reading, you confirm you are a licensed healthcare professional and will apply this information within your clinical judgment, professional obligations, and applicable regulations.
Get the inside scoop on the latest longevity medicine, research, and expert insights from the world’s top longevity doctors. Stay ahead of the curve and be part of the expert community shaping the future of longevity medicine.
Choosing a selection results in a full page refresh.
Meet the leaders on stage June 10 at longevitydocs.™ Cannes Summit & Awards
Meet the leaders on stage June 10 at longevitydocs.™ Cannes Summit & Awards
In just a few weeks, the world's top physicians, researchers, and industry leaders come together at longevitydocs.™ Cannes to build the future of longevity medicine. Attend because you're building, scaling, leading.... and you need the people in this room. Explore the minds shaping longevity medicine on the stage with us June 10, 2026.
In just a few weeks, 250+ physicians and 40+ speakers from 20+ countries come together to learn, build, and scale longevity medicine - and Cannes becomes the home of longevity medicine. This is where the frontier meets the clinic, research becomes practice, and you meet the people you'll build with for years to come.
Creating the experience in Cannes isn't about simply filling an agenda. Every person on this stage was curated because they are shaping the future of longevity medicine. Every moment is designed to mean something, one after the other. This is an intentional experience for physicians at every stage of the journey whether you are dreaming, building, or leading.
What's even more important to us is the voices on the stage that invite us in. The moments to connect with your peer community. Together we will advance the industry with evidence, ethics and equity... This is where longevity medicine becomes standard of care. Join us.
THIS Conversation ADVANCES THE LONGEVITY INDUSTRY
Longevity medicine is no longer a niche practice. It's becoming the default. The field is moving faster than consensus can form, and physicians are making critical decisions with incomplete information. The speakers on our stage aren't waiting for consensus, they're building it. They're the ones who prove what works, who scale what's evidence-based, who navigate the regulatory landscape, and who build practices that survive.
This is where you meet them. Where you understand not just what they know, but how they think. Where you see the patterns that connect senolytic science to peptide protocols, AI implementation to organizational strategy. From Mayo Clinic, Mount Sinai to L'Oréal, these are the physicians, scientists, investors, and innovators who aren't waiting for the future of longevity; they're building it. What you do with this knowledge is what defines the next decade of longevity medicine.
Community Comes First AT LONGEVITYDOCS
The most important moments at this summit don't happen on stage. They happen on the beach at lunch, in the run club rotation, in the garden during the reception. They happen when a physician from Singapore sits next to a founder from Boulder, when a health system CMO asks a clinical question that becomes the next day's conversation.
You're not here to sit and listen. You're here to build. With these people. Over these three days. This is where the longevity field actually moves forward—not in the keynotes, but in the relationships. In the advisory boards formed over dinner. In the referral networks that start with a conversation on the red carpet. In the clinical partnerships that reshape how medicine gets practiced.
Part I: Set The Standard – June 10 Agenda
LongevityDocs Run Club – La Croisette
The day starts the way longevity physicians should start every day: moving. We inaugurate the LongevityDocs Run Club with a 30-minute Zone 2 run along La Croisette. Every few minutes, you rotate conversation partners. By the time you reach the pier, you've already met your first circle. Led by Paul Alexandrov, MD, and Vikas Mehta, MD. Powered by Eli Health.
Terrasse French Breakfast – Vibrant Lounge
Croissant, coffee, and conversations after the run. The formal program hasn't started yet, but the community already has.
Welcome Back to Medicine
Thomas de Pariente, Deputy Mayor of Cannes, opens the summit and our founder, Dr. David Luu will kick us off with the question: how do we scale physician-led longevity care with evidence, ethics, and equity? This is why we're here.
longevitydocs Cannes June 10 Sessions at-a-Glance
Targeting Aging – Nir Barzilai, MD
Where science is and where medicine should be. What's the state of longevity science in 2026, and where should medicine actually be? Barzilai has spent a career answering this question. The TAME trial exists because he proved something most physicians didn't believe: aging itself is treatable. Now the FDA agrees. On June 10, he opens the summit with the science that's changed everything—and what it means for how you practice right now.
What You'll Learn
The AI-Augmented Physician – Ami Bhatt, MD & Zahi Fayad, PhD
AI is already changing how longevity physicians practice. Diagnostics are faster. Risk prediction is more accurate. Treatment can be personalized like never before. But how do you implement this safely? What does the regulatory landscape actually look like? And when AI makes a recommendation, who's responsible?
What You'll Learn
The GLP-1/Peptide Tsunami – Geoff Cook, Jeffrey Egler, MD & Steven Murphy, MD
Are all peptides created equal? Patients want GLP-1s. Your competitors are launching peptide programs. Regulations are shifting. How do you build a safe, evidence-based, profitable peptide strategy in 2026? Three leaders who've done this—from biotech to pharmacy to practice—unpack what actually works.
What You'll Learn
Chief Longevity Officer – Dawn Mussallem, DO, Jessica Shepherd, MD & Saad Alam
A role that's barely a title (yet). One that will be everywhere by 2027. Health systems are asking: Who owns our longevity strategy? Three leaders building this role from scratch map out what it actually looks like. A panel mapping out a role that barely exists, and is about to be everywhere.
What You'll Learn
From Lab to Shelf – Vania Lacascade, PharmD
Inside Lancôme's journey from longevity science to global launch. What happens when a Fortune 500 beauty company decides longevity science is its future? How do you move from diagnostic insight to technology to product at global scale? Lacascade has done this. The insights she's learned are adaptable to your own practice, even if you're not building for billions.
What You'll Learn
Longevity Founders Mode – Jonathann Kuo, MD, Amanda Kahn, MD, Jila Senemar, MD & Ken Winnard, MD
Behind the practice: the wins, the scars, the lessons. Four physicians building four different longevity models in different markets. They've made mistakes that cost time and money. They've been tempted to quit. But they've also learned what actually works. This is the session where they share it. Founders share their journeys building longevity practices: from solo to 65-person teams, from zero patients to six-month waitlists, from community-building to brick-and-mortar centers.
What You'll Learn
Confessions of a Longevity Doctor – Elizabeth Yurth, MD & Cynthia Keller, MD
After 20 years: what works, what's missing. An honest conversation about two decades on the frontier of longevity medicine. Which therapies have stood the test of time? Which ones looked promising but didn't? And what are the unglamorous, consistent interventions that actually move the needle in real patients?
What You'll Learn
Part II: Celebrating Excellence in Longevity Medicine
June 10 ends where every great gathering should: together. The black-tie gala at the iconic Carlton Hotel is the most exclusive night in longevity medicine: one red carpet, one room, one community.
Garden Reception – Carlton Hotel
In the tropical gardens, powered by Hims & Hers. First drinks, first photos, the first time the CLD cohort, Faculty, and Awardees are in the same space.
Certified Longevitydocs CLD Graduation – Class of 2026
We celebrate a cohort of physicians who completed 100 hours of evidence-based longevity medicine training and earn the CLD certification. This will become a credential the field will remember.
Longevitydocs Awards – Grand Salon
Five awards, one message: we recognize the people setting the standard.
Frequently Asked Questions About longevitydocs Cannes 2026
What is longevitydocs Cannes 2026?
longevitydocs Cannes 2026 is the world's premier gathering of physicians, researchers, and leaders in longevity medicine. Held at the Carlton Hotel in Cannes, France, it brings together 250+ physicians, 40+ speakers from 20+ countries to learn, build, and scale evidence-based longevity medicine.
Who are the speakers at longevitydocs Cannes 2026?
40+ speakers including Nir Barzilai, MD (Academy of Geroscience), Ami Bhatt, MD (American College of Cardiology), Zahi Fayad, PhD (Mount Sinai), and leaders from ARPA-H, Hims & Hers, Fountain Life, and more. See the full speaker list and session details.
How do I register for longevitydocs Cannes 2026?
Visit longevitydocs.org/register-cannes-2026 to secure your seat.
Who should attend longevitydocs Cannes 2026?
Physicians building, scaling, or leading longevity medicine. Health system executives. Researchers in aging and healthspan. Entrepreneurs in longevity tech. Anyone advancing evidence-based longevity care and wanting to connect with the field's leading voices.
What is the longevitydocs Certified Longevity Doctor (CLD) credential?
The CLD is the first credentialing program in longevity medicine. 100 hours of evidence-based training covering aging biomarkers, clinical protocols, and practice implementation. Completion is celebrated at the June 10 gala in Cannes.
This article is published exclusively for licensed healthcare professionals. It is not intended for consumers or patients.
All content is for continuing medical education and professional information purposes. It reflects emerging research, science, and technology with implications for medical practice. It does not constitute medical advice, clinical recommendations, or treatment guidance for any individual patient.
By reading, you confirm you are a licensed healthcare professional and will apply this information within your clinical judgment, professional obligations, and applicable regulations.